Precise small molecule and large molecule bioanalysis entail robust quantitation of drug compounds and biomarkers. Our veteran team has an excellent track record of advancing the critical PK, BA/BE, TK, immunogenicity, biomarker, and custom bioanalytical assays across discovery, preclinical, and clinical studies. We offer small molecule bioanalysis and large molecule bioanalysis such as method development, validation, and sample analysis in R&D and GLP/GCP setting using LC-MS/MS, ELISA, MSD, qPCR, Western Blot, and Luminex, among other technologies.
NorthEast BioLab has earned a deep-rooted reputation for small molecule bioanalysis since our founding in 2003. In this regard, we have efficiently delivered numerous biotech and pharmaceutical research studies on platforms such as LC-MS/MS, HPLC/FL, and HPLC/UV. Fast forward to today, we aim to continue our leadership within bioanalytical sciences as per our foundational principles. To that end, we have further broadened our scientific expertise by making significant strides towards biologics bioanalysis over the past few years.
Specifically, we have meaningfully extended our custom assay capabilities for large molecule bioanalysis through enzyme-linked immunosorbent assay (“ELISA”). Although ELISA assays were first developed in the 1970s, advances in digitization and automation have since improved their sensitivity and throughput dramatically. Consequentially, these gold-standard assays have become known for their diverse and optimal applications. Fast forward to today, we utilize MSD, qPCR, Western Blot, and Luminex, and other modern bioanalysis techniques for the promising future of biotech and pharmaceutical research.
NorthEast BioLab is by far the most responsive and thorough bioanalysis lab services CRO.
We partnered on several programs and found NorthEast BioLab responsive, collaborative, and reliable.
We trust NorthEast BioLab to design and execute the most streamlined and impactful bioanalytical projects.
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data.
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism.
NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.
NorthEast BioLab truly goes that extra mile, and we hope to continue enjoying seminal interactions with them.
NorthEast BioLab presents a science-based, hands-on, no-frills approach on the latest bioanalytical platforms.
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
This study, same as all other bioanalytical studies with NorthEast BioLab, was completed with top quality and reporting standard with incredible responsiveness.
As a small company, our vendors are key members of our project teams. The scientists at NorthEast BioLab are technical experts, who produce high-quality data, on-time, and on-budget.
We offer a broad array of small and large molecule bioanalysis services to help our clients navigate the scientific and regulatory challenges in the dynamic and evolving industry. Our bioanalytical expertise includes Method Development and Validation, and Analytical Quantitation of Drugs and Biomarkers. Furthermore, below’s a list of our popular services –
In summary, we understand your burning desire to improve the current standard of care and provide better treatment options to underserved patients. Similar passion served as the cornerstone of our team when we established NorthEast BioLab in 2003. Our clients would agree that it still plays an instrumental role in our client-centric approach today.
Bioanalysis is an essential tool in drug discovery and development for determining the concentration of drugs and their metabolites as well as various pharmacodynamics biomarkers in biological fluids. In these analyses, scientists use developed an….
Our scientists, at NorthEast BioLab, share a passion for facilitating cutting-edge treatments of life-threatening diseases. Thus, we continue to drive high-quality, innovative drug development and research. Additionally, we persistently strive to fulfill biotech and pharmaceutical research needs to the satisfaction of our clients. As a result, we sometimes opportunistically enhance our solutions to address the fast pace of change in science and medicine.
Put differently, we are known for our client-centric approach toward building partnerships and overcoming obstacles during drug development. Furthermore, we maintain a 100% process transparency that is uniformly appreciated by all our clients. Mostly, we take on ourselves to collaborate with internal teams and other vendors to achieve our shared goals and explore the uncharted territories. When permitted, this delivery approach has regularly opened quite a few doors of opportunities for our clients.
Ultimately, NorthEast BioLab thrives on the mission of realizing and reaching the maximum potential of each internal or external team member. Among other advantages, our narrow focus on your biotech and pharmaceutical research allows us to make your company’s drug development program successful. All we request is that you try us to experience our first-class services – notably discovery, preclinical, and clinical development bioanalysis.
